Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Anti-Hypertensive Drugs Market Size Changed, over the years?

The market size for anti-hypertensive drugs has consistently expanded in the past few years. It’s predicted to increase from $36.66 billion in 2024 to $37.5 billion in 2025, showing a compound annual growth rate (CAGR) of 2.3%. The escalation in the past can be ascribed to environmental and lifestyle factors, previous market competition, traditional treatment tendencies, economic variables, and past worldwide health trends.

How Much Will the Anti-Hypertensive Drugs Market Be Worth in 2029?

In the forthcoming years, it is predicted that the market size of anti-hypertensive drugs would witness slight expansion. The market is forecasted to attain a value of $40.41 billion in 2029, growing at a compound annual growth rate (CAGR) of 1.9%. The growth during the predicted period can be accredited to the affordability and cost-effectiveness of these drugs, advancements in therapeutic innovations, epidemiological patterns, modifications in regulations and approvals, demographical changes in the elderly population, as well as alterations in healthcare policies and reimbursements. The key trends for the forecast period comprise therapeutic innovation, changes in epidemiology, regulatory environment, healthcare policies, and progress in diagnosis and monitoring techniques.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

Which is the Largest Company in the Anti-Hypertensive Drugs Market?

Major companies operating in the anti-hypertensive drugs market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, Torrent Pharmaceuticals Ltd, Noden Pharma DAC, Actelion Pharmaceuticals Ltd.

What Are the Main Market Drivers in the Anti-Hypertensive Drugs Industry?

The anti-hypertensive drug market’s expansion is primarily fueled by a sedentary lifestyle. Factors such as unhealthy eating habits, absence of a well-balanced diet, and insufficient sleep driven by erratic work schedules lead to a surge in hypertension cases. Hypertension accounts for about 45% of heart disease fatalities and 51% of stroke-related deaths. Upon diagnosis of hypertension, the intensity of the disease determines the prescription of medication to manage it. The National Health Service, a UK government department, reported in May 2023 that hypertension prevalence escalates with age, rising from 9% in people aged 16 to 44 to 60% in those over 65. This steadily growing need for anti-hypertensive medications serves as a significant catalyzer for the market’s advancement.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2410&type=smp

How Is the Anti-Hypertensive Drugs Market Segments Structured?

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Subsegments:

1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics

2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan

3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril

4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol

5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin

6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

7) By Renin Inhibitors: Aliskiren

8) By Vasodilators: Hydralazine, Minoxidil

What Strategic Trends Are Transforming the Anti-Hypertensive Drugs Market?

In the anti-hypertensive drugs market, principal corporations are putting their focus on pioneering new products like Metoprolol Succinate Extended-Release Tablets to gain a competitive advantage. These tablets are explored as anti-hypertensive medication for hypertension patients. For example, in June 2023, Granules India Limited, a pharmaceutical manufacturing enterprise based in India, introduced Metoprolol Succinate Extended-Release Tablets which had gotten the green light from the Food and Drug Administration (FDA), a US federal agency. These tablets, developed as anti-hypertensive medication, aim to treat hypertension by lowering blood pressure. They are being offered in various concentrations such as 25mg, 50mg, 100mg, and 200mg. Containing beta-blockers, these medications lower heart rate, lessen the heart’s burden, and reduce blood pressure.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Which Global Regions Offer the Highest Growth in the Anti-Hypertensive Drugs Market?

North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2410

This Report Delivers Insight On:

1. How big is the anti-hypertensive drugs market, and how is it changing globally?

2. Who are the major companies in the anti-hypertensive drugs market, and how are they performing?

3. What are the key opportunities and risks in the anti-hypertensive drugs market right now?

4. Which products or customer segments are growing the most in the anti-hypertensive drugs market?

5. What factors are helping or slowing down the growth of the anti-hypertensive drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model